
EXPERIENCE OF ADMINISTRATION OF CANAKINUMAB, AN INTERLEUKIN 1β INHIBITOR, IN A PATIENT WITH CHRONIC TOPHACACEOUS GOUT
Author(s) -
М. С. Елисеев,
О.В. Желябин,
В Г Барскова,
Евгений Львович Насонов
Publication year - 2014
Publication title -
naučno-praktičeskaâ revmatologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.137
H-Index - 9
eISSN - 1995-4492
pISSN - 1995-4484
DOI - 10.14412/1995-4484-2014-99-101
Subject(s) - canakinumab , gout , medicine , dermatology , anakinra , disease